When you sprain your ankle, the swelling that follows is your immune system mobilizing to protect and repair.
This is acute inflammation—purposeful and time-limited.
But there’s another kind of inflammation that is more insidious, and that doesn’t announce itself with visible swelling or obvious pain.
Chronic, low-grade inflammation can smolder silently for years, quietly corroding the body’s systems until it erupts as heart disease, type 2 diabetes, Alzheimer’s, autoimmune disorders, cancer, or simply the accelerated decline we’ve been conditioned to call aging.
But what if that decline isn’t inevitable? A growing body of research suggests that in many cases, chronic inflammation is manageable (and even reversible).
And the tools available are more targeted and scientifically grounded than most people realize. This article explores eight of the most compelling interventions now being used to calm the fire within.
Understanding the Enemy
Before we discuss solutions, it’s worth appreciating the scale of the problem.
Chronic inflammation is now recognized as being a unifying mechanism that underlies virtually every major age-related illness.
And the triggers are everywhere: processed foods, sedentary behavior, chronic stress, poor sleep, environmental toxins, gut dysbiosis, and hormone imbalances.
The result is a body perpetually stuck in “red alert,” unable to repair, regenerate, or rest.
Each of the interventions listed below address the problem from a different angle. Together they form a coherent, multi-pronged strategy.
Low Dose Naltrexone (Resetting the Immune Thermostat)
Naltrexone was originally developed during the 1980s as an opioid antagonist. At doses of 50 mg per day, it was used to block the effects of heroin and alcohol. Later, it was discovered that a tiny fraction of that dose—just 1.5 to 4.5 mg per day—does something entirely different. Rather than blocking opioid receptors, low dose naltrexone (LDN) transiently occupies these receptors, causing the body to dramatically upregulate its own endorphin production.
The downstream effects on inflammation are profound. Elevated endorphins modulate immune function, and LDN has been shown to directly inhibit the process by which the brain’s resident immune cells become chronically inflamed. LDN also appears to reduce pro-inflammatory cytokine production, while preserving the immune system’s ability to fight actual threats.
Unlike broad-spectrum immunosuppressants, LDN does not flatten the immune response. Rather, it recalibrates it. Clinical trials and thousands of patient reports suggest benefits across a remarkably wide range of inflammatory and autoimmune conditions, with a side effect profile that is minimal.
NAD+ (Fueling the Repair Machinery)
Nicotinamide adenine dinucleotide (NAD+) is present within every cell in the body. As an essential cofactor for more than 500 enzymatic reactions, NAD+ is involved in generating ATP (i.e. cellular energy), repairing DNA, regulating gene expression, and modulating the immune response.
However, NAD+ levels decline steeply with age—and chronic inflammation accelerates that decline further. This connection between inflammation and the decline of NAD+ is both bidirectional and vicious. Inflammation depletes NAD+. And low NAD+ impairs the body’s ability to resolve inflammation.
Restoring NAD+ to healthier levels may reverse aspects of cellular aging, improve mitochondrial function, and reduce inflammatory markers. The result can include improvements in metabolic health and cognitive function.
For patients struggling with chronic illness, fatigue, or accelerated aging, NAD+ repletion is increasingly being viewed as a foundational intervention—the very fuel without which every other repair system stalls.
Methylene Blue (The Oldest New Drug)
Methylene blue has a long medical history. It was first synthesized in 1876 and was once widely used to treat malaria and urinary tract infections. Later, it fell out of mainstream medical fashion (in favor of newer solutions for these conditions).
Today, armed with a deeper understanding of mitochondrial biology, researchers are viewing this deep-blue dye through fresh eyes, and finding it may be a versatile anti-inflammatory and neuroprotective compound.
Methylene blue’s core mechanism is elegant. It acts as an electron donor and acceptor within the mitochondrial electron transport chain. The result is improved mitochondrial efficiency, reduced production of reactive oxygen species, and less oxidative stress-driven inflammation.
Methylene blue is also a potent antioxidant, independent of its mitochondrial effects. It has been shown to reduce neuroinflammation, while appearing to be fairly safe and well-tolerated (assuming clinical oversight).
Within the context of chronic inflammation, methylene blue’s power lies in its ability to address inflammation’s root cause (i.e. a failing energy metabolism that leaves cells unable to resolve inflammatory states). If NAD+ is the fuel needed to combat inflammation, methylene blue is the backup generator that keeps the lights on while the main power system is compromised.
Metformin (From Diabetes Drug to Longevity Molecule)
Metformin is the most-prescribed diabetes medication in the world, and for good reason. It’s inexpensive, well-understood, and effective.
But over the past decade, researchers have recognized that its benefits extend beyond blood sugar control. Metformin appears to be a genuine anti-aging, anti-inflammatory compound, with data substantial enough to justify clinical trials that are formally studying its potential for being a longevity drug in non-diabetic populations.
The primary mechanism through which metformin reduces inflammation is the activation of AMPK (AMP-activated protein kinase)—often called the body’s “master energy sensor.” When cells are energy-stressed, AMPK switches on repair and conservation programs and switches off energy-expensive processes like chronic immune activation. Metformin mimics this energy-stressed state, tricking cells into behaving as if they need to be more efficient.
Downstream effects include reduced production of inflammatory cytokines, decreased mTOR signaling (which drives cellular overgrowth and senescence), and improved insulin sensitivity.
Studies have shown that diabetic patients on metformin have lower rates of cancer, cardiovascular disease, and Alzheimer’s disease than would be expected (and lower rates of these conditions than diabetic patients on other medications). The TAME trial (Targeting Aging with Metformin) is currently testing whether metformin can extend healthspan in non-diabetic adults by addressing the inflammatory and metabolic drivers of aging.
For patients with metabolic syndrome, insulin resistance, or chronic inflammation, it’s one of the most evidence-backed tools available.
GLP-1 Agonists (Beyond Weight Loss)
GLP-1 agonists (like semaglutide and tirzepatide) have dominated weight loss headlines for a while now. But researchers are increasingly focused on the anti-inflammatory benefits these medications provide (that operate independently of weight loss).
GLP-1 (glucagon-like peptide-1) is naturally produced within the gut in response to food. Its receptors are found not just in the pancreas (where it stimulates insulin release), but also in the heart, kidneys, liver, brain, and immune cells. And its anti-inflammatory benefits appear to exceed what can be explained by weight loss and glucose control alone.
For patients struggling with obesity-associated inflammation, insulin resistance, or the cluster of metabolic dysfunction that underlies so much chronic illness, GLP-1 agonists provide an intervention whose full anti-inflammatory potential is still being mapped.
Glutathione (The Master Antioxidant)
Every cell in the body produces glutathione—a tripeptide made from glutamine, cysteine, and glycine—and every cell depends on it.
Glutathione is the body’s master antioxidant and detoxifier, responsible for neutralizing the reactive oxygen species that drive oxidative stress, recycling other antioxidants like vitamins C and E, supporting the immune system, and conjugating toxins for elimination.
When glutathione is abundant, cells can weather inflammatory storms. When it’s depleted—by aging, chronic illness, poor diet, alcohol, toxins, or stress—oxidative damage accumulates unchecked.
The relationship between glutathione and inflammation is intimate. The body’s master inflammatory signaling switch is “redox-sensitive”. This means that it’s activated by oxidative stress and suppressed by adequate amounts of glutathione.
Low glutathione levels have been documented in virtually every chronic inflammatory condition studied, including autoimmune diseases, neurodegenerative disease, and cardiovascular disease.
Conversely, restoring glutathione levels consistently reduces inflammatory markers and improves outcomes.
Oral glutathione supplementation was long thought to be futile because the molecule is broken down within the gut before reaching systemic circulation. That picture has changed somewhat with the development of liposomal forms of delivery that survive digestion. Glutathione can also be replenished via self-administered injection.
Patients suffering from chronic illness, a high toxic burden, or post-viral syndromes often report dramatic improvements in their symptoms with glutathione restoration. Without it, no other repair mechanism can function optimally.
Vitamin B12 (The Underestimated Cornerstone)
Vitamin B12 rarely receives dramatic headlines, but its role in regulating inflammation is more central than most people appreciate. And its deficiency is far more common than official statistics suggest.
B12 is essential for the methylation cycle, a biochemical process by which the body controls gene expression, produces neurotransmitters, detoxifies homocysteine, and manages immune function. When B12 is insufficient, methylation falters, homocysteine levels rise, and chronic inflammation follows.
Elevated homocysteine in and of itself is a significant inflammatory risk factor, and is independently associated with cardiovascular disease, cognitive decline, depression, and neurodegenerative conditions. Homocysteine damages blood vessels, promotes oxidative stress, and activates inflammatory pathways. B12, on the other hand (in concert with folate and vitamin B6), is the primary means by which the body eliminates homocysteine.
B12 also plays direct roles in immune system regulation, with B12 deficiency being associated with elevated inflammatory markers. Neurologically, B12 is essential for myelin maintenance, and its depletion can cause subtle but progressive neurological symptoms long before blood counts become overtly abnormal.
For people supplementing B12, the type of B12 being supplemented matters. Cyanocobalamin requires conversion steps that many people—particularly those with MTHFR gene variants—cannot efficiently complete. Methylcobalamin (which is often taken via self-administered injection) is more bioavailable, and therefore more clinically effective.
Balanced Hormones (And the Architecture of Inflammation)
Of all the factors that govern inflammation, few are as consequential—or as systematically overlooked—as hormone balance.
The body’s hormones are not a collection of independent switches. Rather, they are an interconnected system of signals that regulate virtually every physiological process within the body, including immune system function.
When that network is in balance, inflammation is kept in check. When hormones decline or fall out of balance as a result of aging, stress, or illness, the immune system loses its regulatory scaffolding, allowing chronic inflammation to take hold.
Estrogen is one of the most potent natural anti-inflammatory agents within the body. It reduces pro-inflammatory cytokine production and protects against oxidative stress. The steep rise in cardiovascular disease, osteoporosis, cognitive decline, and autoimmune conditions among women after menopause is not coincidental. It tracks directly with the collapse of estrogen levels. Bioidentical estrogen replacement has been shown to reduce inflammatory markers, with women who begin replacement nearest the onset of menopause deriving the greatest protection.
Testosterone is equally important—in both men and women—as an anti-inflammatory signal. Testosterone suppresses inflammatory agents, supports muscle mass (which acts as a metabolic buffer against inflammation), and regulates fat distribution. The decline of testosterone with age—accelerating during the 30s in men and occurring precipitously during perimenopause in women—is strongly correlated with rising inflammatory markers, metabolic syndrome, and visceral fat accumulation. Restoring testosterone to youthful physiological ranges, in both sexes, consistently improves inflammatory profiles.
Progesterone modulates the immune system in ways that are distinct from and complementary to estrogen. In women, it shifts immune responses toward regulatory rather than inflammatory pathways, has neuroprotective properties, and plays a critical role in sleep quality—which is a major determinant of inflammatory status. Most women will benefit from the protective benefits of bioidentical progesterone replacement starting in perimenopause.
DHEA and pregnenolone are precursor hormones produced primarily by the adrenal glands. Both decline dramatically as a consequence of age-related hormone decline, or chronic stress, or both. DHEA has direct anti-inflammatory effects, with low DHEA levels being associated with increased mortality and inflammatory disease burden. Pregnenolone is the hormone from which all steroid hormones (cortisol, estrogen, testosterone, progesterone, and DHEA) are synthesized. When the body is chronically stressed, “pregnenolone steal” (which is a shift in steroid synthesis toward cortisol production at the expense of other hormones) creates widespread hormone deficiencies that can amplify inflammation.
Thyroid is the metabolic thermostat for every cell in the body, regulating the speed at which cells function, repair, and regenerate. Even subclinical hypothyroidism is associated with elevated inflammatory markers. The thyroid hormone system also interacts with mitochondrial function in ways that directly influence the inflammatory response. Patients with undertreated or unrecognized hypothyroidism frequently present with fatigue, brain fog, weight gain, and generalized inflammation that improves significantly with appropriate thyroid support.
Growth hormone (GH) and its downstream mediator IGF-1 decline with age in a process called somatopause. GH has complex effects on inflammation. In physiological amounts, it supports immune system function, promotes tissue repair, reduces visceral fat, and has anti-inflammatory properties. GH deficiency in adults is associated with increased cardiovascular risk, metabolic dysfunction, and markers for accelerated aging. GH levels can be increased via peptide therapies (such as sermorelin) that stimulate natural GH release, or via direct GH replacement (using recombinant growth hormone).
Cortisol, the body’s primary stress hormone, is both an anti-inflammatory signal (when present in healthy amounts) and a pro-inflammatory signal (when excess amounts are present). Short-term cortisol release is essential for regulating the immune response. Chronic stress, however, leads to either persistent cortisol elevation (which causes insulin resistance, visceral fat deposition, and immune dysfunction) or the burnout associated with adrenal fatigue (which leaves the immune system without its most powerful brake). Supporting adrenal function through stress management, sleep optimization, adaptogenic herbs, and balancing other hormones is a critical (and often underemphasized) part of an anti-inflammatory regimen.
What ties all of these hormones together is the recognition that the body functions as a system. Trying to treat inflammation while ignoring hormone imbalances is like trying to fix a house’s electrical problems without checking the breaker panel. Comprehensive hormone optimization—with bioidentical hormones matched to an individual’s physiology and guided by lab testing and clinical expertise—addresses one of the deepest root causes of chronic inflammation.
A Unified Strategy, Not Just a Checklist
What’s striking about these eight interventions is not just that each of them works, but that they work synergistically.
LDN recalibrates the immune system. NAD+ restores the energy that repair processes require. Methylene blue enhances mitochondrial function. Metformin and GLP-1 agonists dial down the metabolic drivers of inflammation. Glutathione neutralizes the oxidative stress that perpetuates the inflammatory cycle. B12 ensures the methylation machinery that governs immune system regulation can function. And balanced hormones provide the body-wide signals that the entire inflammatory control system depends upon.
All of this is to say that chronic inflammation is not a single disease with a single cure. Rather, it is a systemic state that is driven by multiple converging failures. The most effective approach to combatting inflammation addresses those failures simultaneously, guided by comprehensive testing and personalized treatment that is monitored over time. Rather than merely suppressing symptoms, these interventions seek to restore the conditions under which the body can heal itself.
The inflammatory fire within doesn’t have to keep burning. We now have more sophisticated tools available than ever to extinguish that fire. The question is no longer whether chronic inflammation can be addressed— it’s whether or not we’re willing to tackle it.
At Renew Youth, we can put together a comprehensive inflammation-busting treatment plan that is personalized to your needs. Call us at (800) 859-7511 or use our easy contact form to schedule your complimentary 30-minute consultation.